IRVINE, Calif., Nov. 5, 2014 (GLOBE NEWSWIRE) -- Praxsyn Corporation (OTCQB:PXYN) announced today that the majority of its shareholders have voted to change domiciles from the state of Illinois to Nevada. Praxsyn Corporation shareholders entitled to vote authorized the change of domicile via their majority written consent due to: a) Nevada's favorable corporate laws; b) lower corporate income taxes; and c) easily accessible corporate filings through the Nevada Secretary of State's web portal.
"As we continue to focus on the company's growth, moving the corporation's domicile to Nevada is another step in taking Mesa Pharmacy national," said Edward F. Kurtz, Chief Operating Officer, Praxsyn Corporation. "We are excited about the move as it will provide economic and operational benefits for our company."
In addition, Praxsyn Corporation also announced that its majority of shareholders entitled to vote have affirmed the board of directors to consist of Edward Kurtz (chairman of the board), John Garbino, Evon Midei, Jonathan Renkas, M.D., and Kelly Reynolds to serve as members of the board of directors bringing the total number of board members to five.
About Praxsyn Corporation
Headquartered in Irvine, California, Praxsyn works to realize the vision of medical professionals to improve the lives of patients. Mesa Pharmacy, a wholly owned subsidiary, provides doctors with an alternative to oral pain medications. Mesa focuses on providing custom compounded non-narcotic, transdermal topical pain medications that are marketed to industrial health physicians and medical clinics. Mesa has developed a series of topical creams, in different strengths, that provide the pain relief doctors seek for their patients. Additional company information can be found at www.praxsyn.com.
Forward-Looking Statements
Certain statements made in this press release are forward-looking in nature (within the meaning of the Private Securities Litigation Reform Act of 1995) including but not limited to the statement regarding the anticipated results of the change in domicile, and, accordingly, are subject to risks and uncertainties. The actual results may differ materially from those described or contemplated and consequently, you should not rely on these forward-looking statements as predictions of future events. Certain of these risks and uncertainties are discussed in the reports we filed with the SEC.